Yuan Zhi
Stock Analyst at B. Riley Securities
(4.44)
# 1,201
Out of 5,119 analysts
136
Total ratings
40.5%
Success rate
15.8%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STLN Starling Oncology | Reiterated: Buy | $11 → $10 | $3.62 | +176.24% | 4 | Nov 6, 2026 | |
| MIR Mirion Technologies | Reiterated: Buy | $29 → $25 | $17.97 | +39.12% | 12 | Oct 29, 2026 | |
| PGEN Precigen | Reiterated: Buy | $12 | $4.47 | +168.46% | 2 | Oct 27, 2026 | |
| LYEL Lyell Immunopharma | Reiterated: Buy | $44 | $14.86 | +196.10% | 2 | Sep 24, 2026 | |
| NUTX Nutex Health | Reiterated: Buy | $325 | $180.56 | +80.00% | 1 | Sep 4, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $129 → $105 | $100.61 | +4.76% | 28 | Aug 18, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2 → $1.6 | $0.7195 | +122.38% | 9 | Aug 10, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $10 | $3.13 | +219.49% | 1 | Jun 25, 2026 | |
| TNGX Tango Therapeutics | Rated: Buy | $21 → $35 | $21.50 | +62.79% | 7 | Jun 9, 2026 | |
| RDNT RadNet | Rated: Buy | $87 → $83 | $76.00 | +9.21% | 6 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $5.56 | +43.88% | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $13 | $0.84 | +1,447.62% | 13 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.87 | +434.76% | 2 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $0.9588 | +1,568.75% | 6 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $4.80 | n/a | 3 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $2 | $1.43 | n/a | 13 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $19 → $15 | $19.10 | n/a | 14 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 | $39.16 | n/a | 12 | Feb 7, 2024 |
Starling Oncology
Nov 6, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $3.62
Upside: +176.24%
Mirion Technologies
Oct 29, 2026
Reiterated: Buy
Price Target: $29 → $25
Current: $17.97
Upside: +39.12%
Precigen
Oct 27, 2026
Reiterated: Buy
Price Target: $12
Current: $4.47
Upside: +168.46%
Lyell Immunopharma
Sep 24, 2026
Reiterated: Buy
Price Target: $44
Current: $14.86
Upside: +196.10%
Nutex Health
Sep 4, 2026
Reiterated: Buy
Price Target: $325
Current: $180.56
Upside: +80.00%
Lantheus Holdings
Aug 18, 2026
Downgraded: Hold
Price Target: $129 → $105
Current: $100.61
Upside: +4.76%
Hyperfine
Aug 10, 2026
Reiterated: Buy
Price Target: $2 → $1.6
Current: $0.7195
Upside: +122.38%
Whitehawk Therapeutics
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $3.13
Upside: +219.49%
Tango Therapeutics
Jun 9, 2026
Rated: Buy
Price Target: $21 → $35
Current: $21.50
Upside: +62.79%
RadNet
May 1, 2026
Rated: Buy
Price Target: $87 → $83
Current: $76.00
Upside: +9.21%
Mar 25, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $5.56
Upside: +43.88%
Mar 18, 2026
Rated: Buy
Price Target: $11 → $13
Current: $0.84
Upside: +1,447.62%
Dec 17, 2025
Reiterated: Buy
Price Target: $10
Current: $1.87
Upside: +434.76%
Dec 16, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $0.9588
Upside: +1,568.75%
Oct 2, 2024
Reiterated: Buy
Price Target: $4 → $3
Current: $4.80
Upside: n/a
Aug 7, 2024
Downgraded: Hold
Price Target: $16 → $2
Current: $1.43
Upside: n/a
Jul 30, 2024
Upgraded: Buy
Price Target: $19 → $15
Current: $19.10
Upside: n/a
Feb 7, 2024
Reiterated: Buy
Price Target: $79
Current: $39.16
Upside: n/a